Articles

P1.02 In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma

BJH - volume 6, issue Abstract Book BHS, january 2015

K. Maes , E. De Smedt , A. Kassambara , D. Hose , A. Seckinger , E. Van Valckenborgh PhD, E. Menu , B. Klein , K. Vanderkerken PhD, J. Moreaux , E. De Bruyne

Read more

O.5 In vivo gene expression profiling in the murine 5T33MM model identifies epigenetic-regulated genes predictive for prognosis and drug-sensitivity

BJH - volume 5, issue Abstract Book BHS, january 2014

K. Maes , E. De Smedt , D. Hose , E. Van Valckenborgh PhD, E. Menu , B. Klein , K. Vanderkerken PhD, J. Moreaux , E. De Bruyne

Read more

P2.16 Activation of invariant natural killer T cells reduces angiogenesis in the 5T33 multiple myeloma model

BJH - volume 5, issue Abstract Book BHS, january 2014

H. Nur , L. Rao , A. Vacca , D. Elewaut , E. Van Valckenborgh PhD, E. De Bruyne , K. Vanderkerken PhD, E. Menu

Read more

P3.02 Bone Marrow Stromal Cell-derived Exosomes Facilitate Multiple Myeloma Cell Survival Through Inhibition of the JNK Pathway

BJH - volume 5, issue Abstract Book BHS, january 2014

J. Wang , A. Hendrix , E. De Bruyne , E. Van Valckenborgh PhD, E. Himpe , B. De Beule , O. De Wever , K. Vanderkerken PhD, E. Menu

Read more

P.05 The Combination of Decitabine and the Histone Deacetylase Inhibitor JNJ-26481585 Has Synergistic Anti-Myeloma Activity

BJH - 2013, issue BHS Abstractbook, january 2013

K. Maes , M. Lemaire , E. De Smedt , E. Menu , E. Van Valckenborgh PhD, K. Vanderkerken PhD, E. De Bruyne

Read more

P.27 Invariant Natural Killer T cells in the 5T33 multiple myeloma model

BJH - 2013, issue BHS Abstractbook, january 2013

H. Nur , K. Fostier MD, S. Aspeslagh , W. Renmans , E. Bertrand , X. Leleu , K. Breckpot , R. Schots MD, PhD, M. De Waele , E. Van Valckenborgh PhD, E. De Bruyne , T. Facon , D. Elewaut , K. Vanderkerken PhD, E. Menu

Read more

P.28 The IGF-1 receptor inhibitor picropodophyllin (PPP) potentiates the anti-myeloma effects of the BH3 mimetic ABT-737

BJH - 2013, issue BHS Abstractbook, january 2013

L. Bieghs , E. Van Valckenborgh PhD, E. Menu , M.T. Overgaard , M. Nyegaard , H. Johnsen , O. Larsson , H. Jernberg-Wiklund , K. Vanderkerken PhD, E. De Bruyne

Read more